IP Address: | 69.63.140.80 |
---|---|
IP Block: | 69.63.138.0 - 255.255.255.255 |
Reverse DNS: | ewhserver1302.edgewebhosting.net |
Host: | Databank Holdings Ltd |
Location: | Dallas, TX, US |
Time Zone: | America/Chicago |
Current Time: | 9:37 AM on May. 12, 2025 |
Page Load Time: | 0.219 secs. |
Server Type: | Apache |
Date Registered: | Unavailable |
---|---|
Date Updated: | Unavailable |
Date Expires: | Unavailable |
Registration Length: | (Unavailable) |
WHOIS Registrar: | Unavailable |
WHOIS Server: | Unavailable |
Domain Status: | Unavailable |
DNS Nameservers: | ns59.domaincontrol.com ns60.domaincontrol.com |
Title: | Neoleukin Therapeutics | de novo Protein Design |
---|---|
Description: | Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and autoimmunity. |
Category: | Unavailable |
Keywords: | Unavailable |
Plot IP Analysis: | The domain neoleukin.com is hosted from IP address 69.63.140.80, having reverse-lookup ewhserver1302.edgewebhosting.net and inward-pointing nameservers ns59.domaincontrol.com, and ns60.domaincontrol.com. Our records show that other domains are hosted from this IP, such as affymax.com, zosanopharma.com, and xocpharma.com, among others. The server hosting neoleukin.com is located in a data center in Dallas, TX, United States of America. |